Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

172 results about "Bridging ligand" patented technology

In coordination chemistry, a bridging ligand is a ligand that connects two or more atoms, usually metal ions. The ligand may be atomic or polyatomic. Virtually all complex organic compounds can serve as bridging ligands, so the term is usually restricted to small ligands such as pseudohalides or to ligands that are specifically designed to link two metals.

Hybrid nanoparticles as Anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents

The presently disclosed subject matter provides nanoscale coordination polymers for use as anticancer agents and as dual anticancer / imaging agents. The nanoscale coordination polymers can comprise a plurality of platinum metal complexes; nonplatinum anticancer drug bridging ligands complexed to multiple metal centers; or combinations thereof. The nanoscale coordination polymers can be targeted for delivery to cancer cells. They can also comprise stabilizing agents to allow for controlled and / or sustained release of anticancer agents in vivo.
Owner:THE UNIV OF NORTH CAROLINA AT CHAPEL HILL

Nanoparticles for photodynamic therapy, x-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof

Metal-organic frameworks (MOFs) comprising photosensitizers are described. The MOFs can also include moieties capable of absorbing X- rays and / or scintillation. Optionally, the photosensitizer or a derivative thereof can form a bridging ligand of the MOF. Further optionally, the MOF can comprise inorganic nanoparticles in the cavities or channels of the MOF or can be used in combination with an inorganic nanoparticle. Also described are methods of using MOFs and / or inorganic nanoparticles in photodynamic therapy or in X-ray induced photodynamic therapy, either with or without the co-administration of one or more immunotherapeutic agent and / or one or more chemotherapeutic agent.
Owner:UNIVERSITY OF CHICAGO

Metal-organic frameworks, and pharmaceutic preparation and application thereof

The present invention provides metal-organic frameworks, and pharmaceutic preparation and application thereof. The metal-organic frameworks (MOFs) comprising photosensitizers are described. The MOFs can also include moieties capable of absorbing X- rays and / or scintillation. Optionally, the photosensitizer or a derivative thereof can form a bridging ligand of the MOF. Further optionally, the MOF can comprise inorganic nanoparticles in the cavities or channels of the MOF or can be used in combination with an inorganic nanoparticle. Also described are methods of using MOFs and / or inorganic nanoparticles in photodynamic therapy or in X-ray induced photodynamic therapy, either with or without the co-administration of one or more immunotherapeutic agent and / or one or more chemotherapeutic agent.
Owner:UNIVERSITY OF CHICAGO

Tetrapyridylporphine bridged crossed tetra-palladium complexes, and preparation method and antitumor activity thereof

The invention relates to a preparation method of tetra-palladium complexes in a crossed structure which synthesize tetrapyridylporphine bridge by using supramolecular self-assembly. The tetra-palladium complexes are possibly used for treating human cancers. The MTT experiment data indicates that the compounds have high antitumor activity. A single-teeth platinum ligand, of which the chloride ion is substituted by nitrate, and a bridging ligand tetrapyridylporphine are subjected to self-assembly, thereby obtaining new potential anticancer drugs with excellent anticancer activity and tumor targeting property. The complexes have excellent tumor cell targeting property, and induce the G-rich sequence of the cancer gene to form a G-quadruplex structure, thereby inhibiting the activity of the telomere enzyme and further having high antitumor activity. In addition, since the preparation method is simple and easy to implement, has lower cost, and can be complemented in a common chemical laboratory, and does not have environment pollution in the production process. Therefore, the tetrapyridylporphine bridged tetra-palladium complexes in a crossed structure can be used as novel potential antineoplastic drugs.
Owner:SUN YAT SEN UNIV

Binuclear cuprous complex luminescent material and preparation method thereof

The invention discloses a binuclear Cu(I) complex luminescent material capable of emitting green light and a preparation method of the binuclear Cu(I) complex luminescent material. The green luminescent complex is obtained by complexing cuprous bromide and a ligand, and the molecular structure is [Cu(POP)Br]2, wherein the POP in the formula is an electric neutrality ligand bis(2-diphenyl phosphorus phenyl)ether, and the binuclear structure molecule is formed by coupling a bridging ligand bromide ion with two metal ions. The complex has the advantages that the micromolecule is easy to purify and the luminous efficiency is high, and the heat stability is high. The material is obtained by directly mixing and reacting the cuprous bromide with a dichloromethane solution of the ligand, the process is simple and convenient, the equipment is simple, the raw material is easy to obtain and the cost is low. The material can be used as a photoluminescence green material, and can be further used as a luminescent layer green material in an electroluminescent device composed of multilayer organic materials.
Owner:CHINA JILIANG UNIV

Separation and purification process of taurine

The invention relates to a separation and purification process of taurine and is applicable to methods for synthesizing taurine from ethylene oxide as a raw material. The process specifically comprises the following steps: mixing ethylene oxide with sodium hydrogen sulfite and other gas, liquid and solid-phase catalysts and nanoparticles by using an ionization multi-channel nozzle device so as toprepare sodium 2-hydroxyethanesulfonate, further performing high-temperature high-pressure treatment and concentration so as to prepare sodium taurate, and neutralizing a sodium taurate liquid by using sodium hydrogen sulfite; and in a ceramic nanometer-sized metallomolecular cage component, performing a self-assembling reaction on a three-tooth bridging ligand with sulfur and nitrogen and divalent nickel, palladium or platinum ions so as to establish a cubic metallic-organic cage in Oh symmetry, and performing exchange of hydrogen ions with sodium ions and solvent molecule catalysis simultaneously, so as to obtain the taurine. Mother liquor is subjected to concentration and separation to obtain sodium sulfite which is used as a raw material of an ethylene oxide reaction, an absorption andtransferring carrier of sulfur dioxide and a raw material for neutralizing the sodium taurate liquid. Waste liquid free circulation production of taurine can be achieved.
Owner:王建峰

Di-nuclear cuprous complex green luminescent material and preparation method thereof

The invention discloses a di-nuclear cuprous complex green luminescent material and a preparation method thereof. The green luminescent complex provided by the invention is prepared by complexing cuprous iodide and a ligand, and the molecular structure of the complex is [CuI(DPPB)]2, wherein the DPPB in the formula is an electro-neutral 1,4-di(diphenylphosphine) butane containing a ligand P, and iodide ions of a bridging ligand are connected with the centers of two metal ions to form a di-nuclear structural molecule. The complex not only has the advantages that small molecules are easy to purify and the luminous efficiency is high but also has high thermal stability. The material is prepared through a direct mixing reaction between the cuprous iodide and a dichloromethane solution of the ligand, and has the advantages of simple and convenient process, simple equipment, easily-obtainable raw materials, low cost and the like. The material can be used as a green photo-luminescent material or used as a green luminescent layer material in an electroluminescent device consisting of a plurality of layers of organic materials.
Owner:CHINA JILIANG UNIV

Ir (III)-Eu (III) thermometal complex and application thereof

The invention discloses an Ir (III)-Eu (III) thermometal complex and an application thereof. A structural formula of the Ir (III)-Eu (III) thermometal complexes is [(L1L2) Ir (Mu-B)] mEu (D1D2D3) En, wherein B represents a carboxy-substituted bridging ligand derived from bipyridyl; L1 and L2 represent a cyclometalated ligand combined with Ir; D1, D2 and D3 represent anionic ligands; E represents a neutral ligand; m equals to 1, 2 or 3; n is an integer ranging from 0-8; and the specific values depend on coordination structures and the overall coordination environment of the ligands, totally the coordination number of an Eu (III) ion ranges from 6 to 12. The europium complex has efficient photoluminescence quantum yield, and can realize visible light excitation of a long wavelength, and can be used as functional material for photoluminescence.
Owner:PEKING UNIV

Trinuclear platinum complex possessing Y type structure and its targeting for gastric adenocarcinoma cells

The invention relates to a preparation method of an organic hybrid trinuclear platinum complex possessing a Y type structure synthesized by supermolecules self-assembly as well as treatment for gastric adenocarcinoma cells. The MTT experiment data shows that the compound can cross a drug resistance mechanism of cisplatin, and can specifically target to the gastric adenocarcinoma cells. A platinum ligand Pt(NH3)2Cl(NO3)] in which the chloride ion is replaced by nitrate and a bridge ligand (2,4,6-tri(pyridin-4-yl)-1,3,5-triazine) are subjected to self-assembly, thereby the novel and latent medicine for treating gastric adenocarcinoma with excellent anticancer activity and tumor targeting is obtained. Because the complex enables specific recognition of the gastric adenocarcinoma cells, and can induce the G-rich sequence of the oncogene to form a G-quadruplex structure, the activity of telomerase can be inhibited, thereby the complex possesses high gastric adenocarcinoma resistance activity. The preparation method has the advantages of simple process and low cost, can be completed in a general chemical laboratory, and the production process is environmentally-friendly. The trinuclear platinum complex possessing Y type structure can be taken as the novel and latent gastric adenocarcinoma resistance medicine.
Owner:SUN YAT SEN UNIV

Taurine separation and purification device

The invention relates to a taurine separation and purification device. The taurine separation and purification device is suitable for a method for synthesizing taurine by taking oxirane as a raw material. The method specifically includes the steps that an ionization multi-channel nozzle device is utilized to mix the oxirane with sodium hydrogen sulfite and other gas, liquid and solid phase catalysts through nanoparticles to prepare sodium 2-hydroxyethanesulfonate, then sodium taurate is prepared through the high temperature and high pressure and concentration, and the sodium hydrogen sulfite is adopted to neutralize sodium taurate material liquid; and in a ceramic nano metal molecular cage assembly, through a self-assembly reaction of a tridentate bridging ligand containing organic sulfurand nitrogen and bivalent nickel, palladium or platinum ions, a cubic metal-organic cage with O<h> symmetry is constructed, meanwhile, exchange of hydrogen ions and sodium ions and solvent molecular catalysis are accommodated, and thus the taurine is obtained. A mother solution is concentrated and separated to obtain sodium sulfite to serve as a raw material of an oxirane reaction, a carrier for absorption and transport of sulfur dioxide, and a raw material for neutralization of the sodium taurate material liquid. Waste-liquid-free cycle production of the taurine is achieved.
Owner:王建峰

Cu-Eu red fluorescent and magnetic microporous structure complex and preparation method thereof

The invention discloses a Cu-Eu red fluorescent and magnetic microporous structure complex and a preparation method thereof. The preparation method comprises the following steps: by taking pyridine dicarboxylic acid as a bridging ligand, dissolving pyridine dicarboxylic acid into deionized water according to a certain molar ratio, adding CuCl2 and EuCl3, stirring and filtering to obtain a light blue solution, and standing for three days to obtain blue-green hexagonal micro-crystals. A prepared 3d-4f metal compound can be used for greatly improving the photo-conversion efficiency based on the ligand, copper ions and pyridine dicarboxylic acid can play roles as antennae and can be used for transferring the energy of ultraviolet light to rare earth ions, and by virtue of the 3d-4f metal compound, the copper ions and pyridine dicarboxylic acid, novel geometric and topological structures can be provided, and the overall luminous efficiency of the complex can also be improved. According to the complex disclosed by the invention, metal ions are in anti-ferromagnetic coupling in a range of 300-100K, and the metal ions have ferromagnetic coupling interaction effects in a range of less than 100K.
Owner:NORTHEASTERN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products